Litcius/Paper detail

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?

Ιrene Karampela, Μaria Dalamaga

2020Archives of Medical Research130 citationsDOIOpen Access PDF

Topics & Concepts

MoxifloxacinLevofloxacinMedicinePharmacologyPneumoniaGatifloxacinGemifloxacinAntibioticsVirologyMicrobiologyBiologyInternal medicinePneumonia and Respiratory InfectionsAntibiotics Pharmacokinetics and EfficacyPneumocystis jirovecii pneumonia detection and treatment
Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19? | Litcius